Tracking transplanted retinal cells to improve vision restoration
Nanoparticle-Based Tracking of Retinal Ganglion Cell Transplant
This study is looking at how tiny particles can help doctors see and track transplanted cells in the eye, which could lead to better treatments for people with retinal diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11259044 on NIH RePORTER |
What this research studies
This research focuses on improving cell transplant therapies for retinal diseases by using nanoparticles to track retinal ganglion cells (RGCs) in real-time. The approach involves customizing nanoparticles to enhance imaging techniques, allowing researchers to visualize and monitor the behavior of transplanted cells in the eye. By understanding how these cells behave and the factors affecting their success, the research aims to optimize transplant procedures and improve outcomes for patients with degenerative eye conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from degenerative retinal conditions, such as glaucoma or age-related macular degeneration.
Not a fit: Patients with non-degenerative eye conditions or those who do not have retinal ganglion cell damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for vision loss caused by retinal diseases.
How similar studies have performed: Previous research has shown promise in using nanoparticle-based imaging techniques for tracking cellular therapies, indicating a potential for success in this novel application.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Chen, Fang — Case Western Reserve University
- Study coordinator: Chen, Fang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.